www.EXFILE.com -- 888.775-4789 == BOSTON SCIENTIFIC CORP. FORM 8K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
 
 
FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of Report (Date of earliest event reported):     November 7, 2007

 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)

DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
    

One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)

Registrant’s telephone number, including area code:  (508) 650-8000
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
ITEM 1.01.
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
 
On November 7, 2007, we amended the terms of our (a) Credit and Security Agreement, dated as of August 16, 2002, as amended, by and among Boston Scientific Corporation, Boston Scientific Funding LLC, Variable Funding Capital Company LLC, Victory Receivables Corporation, The Bank of Tokyo-Mitsubishi UFJ Ltd., New York Branch and Wachovia Bank, National Association, and (b) Receivables Sale Agreement, dated as of August 16, 2002 between Boston Scientific Corporation and each of its direct or indirect wholly-owned subsidiaries that become a seller thereunder and Boston Scientific Funding LLC, to replace Wachovia Bank, National Association with The Royal Bank of Canada as a lender and the administrative agent under the Credit and Security Agreement, to add a special obligor in order to obtain additional funding availability under the Credit and Security Agreement, to incorporate prior amendments to both agreements, and to make certain other changes to the facilities. Forms of the Amended and Restated Credit and Security Agreement and the Amended and Restated Receivables Sale Agreement are filed with this report as Exhibit 10.1 and Exhibit 10.2, respectively.

 
 
 
 
 
 
 
 
 

 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.

 
Exhibit  No.
 Description
   
10.1  
Form of Amended and Restated Credit and Security Agreement
   
10.2
 Form of Amended and Restated Receivables Sale Agreement
 
 
 
 
 
SIGNATURE


Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
  BOSTON SCIENTIFIC CORPORATION  
     
       
Date:       November 13, 2007
By:
/s/ Lawrence J. Knopf  
    Lawrence J. Knopf  
    Senior Vice President and Deputy General Counsel  
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

EXHIBIT INDEX


 

 
Exhibit  No.
 Description
   
10.1  
Form of Amended and Restated Credit and Security Agreement
   
10.2
 Form of Amended and Restated Receivables Sale Agreement